Research output per year
Research output per year
Personal profile
Headline
CLINICAL INSTRUCTOR / Dermatology
Biography
Dr. Napatalung earned her B.S. degree Summa Cum Laude in2005 from Middle Tennessee State University and her M.D. from University ofTennessee Health Science Center in 2012, earning the Albright Armstrong RiceMerit Scholarship. She did a one-year internship at The Mayo School ofGraduate Medical Education prior to entering her dermatology residency also atThe Mayo School of Graduate Medical Education, where she served as chiefresident and completed in 2016. Since 2017 Dr. Napatalung has served as aMedical Director of Global Medical Affairs for Pfizer where she leads the JAK3alopecia areata and vitiligo programs. Prior to Pfizer Dr. Napatalungserved as Dermatologist at Illinois Dermatology Institute in Chicago, Illinois.
Fingerprint
Dive into the research topics where Lynne Napatalung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
King, B., Zhang, X., Harcha, W. G., Szepietowski, J. C., Shapiro, J., Lynde, C., Mesinkovska, N. A., Zwillich, S. H., Napatalung, L., Wajsbrot, D., Fayyad, R., Freyman, A., Mitra, D., Purohit, V., Sinclair, R. & Wolk, R., 6 May 2023, In: The Lancet. 401, 10387, p. 1518-1529 12 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
George, P., Jagun, O., Liu, Q., Wentworth, C., Napatalung, L., Wolk, R., Anway, S. & Zwillich, S. H., Aug 2023, In: Dermatology and Therapy. 13, 8, p. 1733-1746 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Overview of alopecia areata for managed care and payer stakeholders in the United States
King, B., Pezalla, E., Fung, S., Tran, H., Bourret, J. A., Peeples-Lamirande, K., Takiya, L. & Napatalung, L., Jul 2023, In: Journal of managed care & specialty pharmacy. 29, 7, p. 848-856 9 p.Research output: Contribution to journal › Review article › peer-review
-
Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
Campos-Alberto, E., Hirose, T., Napatalung, L. & Ohyama, M., Jan 2023, In: Journal of Dermatology. 50, 1, p. 37-45 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
George, P., Jagun, O., Liu, Q., Wentworth, C., Napatalung, L., Wolk, R., Anway, S. & Zwillich, S. H., 2023, (Accepted/In press) In: Journal of Dermatology.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
-
New Safety and Efficacy Data of Ritlecitinib for Alopecia Areata Published in The Lancet
1/04/23
1 item of Media coverage
Press/Media